Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Tornier Perform™ Reversed Monopost Study

NCT: NCT07764614 · NOT_YET_RECRUITING

NCT IDNCT07764614
StatusNOT_YET_RECRUITING
Start Date2026-09-28
Completion2031-08-30
SponsorStryker Trauma and Extremities (INDUSTRY)
First posted
Last updated

Brief Summary

This study is a Multi-center, Prospective Follow-up, Non-significant risk, Post-Market Clinical Follow-Up (PMCF) study to Evaluate the Safety and Effectiveness of the Tornier Perform™ Reversed MonoPost System.

Frequently Asked Questions

What is Tornier Perform™ Reversed Monopost Study?

Tornier Perform™ Reversed Monopost Study is a clinical trial registered under NCT07764614. Current status: NOT_YET_RECRUITING.

What is the status of NCT07764614?

The current status of NCT07764614 (Tornier Perform™ Reversed Monopost Study) is: NOT_YET_RECRUITING.

When did Tornier Perform™ Reversed Monopost Study start?

Tornier Perform™ Reversed Monopost Study started on 2026-09-28.

Related Devices

K252788Tornier Perform™ Reversed Monopost Glenoid (Perform Mono)Tornier, Inc. K211359Tornier Perform™ Patient-Matched Primary Reversed Glenoid and BLUEPRINT™ Patient Specific InstrumentationTornier, Inc. K213124Tomier Perform™ Reversed Glenoid Cannulated GlenospheresTornier, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑